517 related articles for article (PubMed ID: 28504115)
1. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
Dai XQ; Cai WT; Wu X; Chen Y; Han FM
Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
[TBL] [Abstract][Full Text] [Related]
2. Oxymatrine Inhibition of Hepatitis B Virus Replication Through ERK1/2 Pathway and HNF1α and HNF4α Block in vitro.
Wang F; Wang X; Ling B; Lu H; Huang J; Zhong T
J Coll Physicians Surg Pak; 2024 Mar; 34(3):329-335. PubMed ID: 38462870
[TBL] [Abstract][Full Text] [Related]
3. Saikosaponin C exerts anti-HBV effects by attenuating HNF1α and HNF4α expression to suppress HBV pgRNA synthesis.
Pan Y; Ke Z; Ye H; Sun L; Ding X; Shen Y; Zhang R; Yuan J
Inflamm Res; 2019 Dec; 68(12):1025-1034. PubMed ID: 31531682
[TBL] [Abstract][Full Text] [Related]
4. Luteolin Inhibits Hepatitis B Virus Replication through Extracellular Signal-Regulated Kinase-Mediated Down-Regulation of Hepatocyte Nuclear Factor 4α Expression.
Bai L; Nong Y; Shi Y; Liu M; Yan L; Shang J; Huang F; Lin Y; Tang H
Mol Pharm; 2016 Feb; 13(2):568-77. PubMed ID: 26656210
[TBL] [Abstract][Full Text] [Related]
5. Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.
Zhao Z; Hong W; Zeng Z; Wu Y; Hu K; Tian X; Li W; Cao Z
J Biol Chem; 2012 Aug; 287(36):30181-90. PubMed ID: 22791717
[TBL] [Abstract][Full Text] [Related]
6. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.
Huang H; Zhou W; Zhu H; Zhou P; Shi X
Toxicol Appl Pharmacol; 2017 May; 323():36-43. PubMed ID: 28322895
[TBL] [Abstract][Full Text] [Related]
7. Baicalin down-regulating hepatitis B virus transcription depends on the liver-specific HNF4α-HNF1α axis.
Xia C; Tang W; Geng P; Zhu H; Zhou W; Huang H; Zhou P; Shi X
Toxicol Appl Pharmacol; 2020 Sep; 403():115131. PubMed ID: 32687838
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
He W; Li LX; Liao QJ; Liu CL; Chen XL
World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-35 stimulates hepatitis B virus transcription and replication by targeting transcription factor HNF4α.
Tao NN; Gong R; Chen X; He L; Ren F; Yu HB; Chen J; Ren JH
J Gen Virol; 2018 May; 99(5):645-654. PubMed ID: 29561254
[TBL] [Abstract][Full Text] [Related]
10. [Role of tumor necrosis factor-alpha in the anti-HBV activity of tetracycline].
Ni Y; Jiang F; Xu H; Zeng T; Lei Y; Chen Y; Zhou Z; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):213-8. PubMed ID: 24824125
[TBL] [Abstract][Full Text] [Related]
11. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatitis B Virus replication by hepatocyte nuclear factor 4-alpha specific short hairpin RNA.
He F; Chen EQ; Liu L; Zhou TY; Liu C; Cheng X; Liu FJ; Tang H
Liver Int; 2012 May; 32(5):742-51. PubMed ID: 22340507
[TBL] [Abstract][Full Text] [Related]
14. ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication.
Wang ZY; Li YQ; Guo ZW; Zhou XH; Lu MD; Xue TC; Gao B
Acta Pharmacol Sin; 2020 Feb; 41(2):278-285. PubMed ID: 31554961
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte nuclear factor 1α downregulates HBV gene expression and replication by activating the NF-κB signaling pathway.
Lin J; Gu C; Shen Z; Liu Y; Wang W; Tao S; Cui X; Liu J; Xie Y
PLoS One; 2017; 12(3):e0174017. PubMed ID: 28319127
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
[TBL] [Abstract][Full Text] [Related]
17. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.
Shi H; Lu L; Zhang NP; Zhang SC; Shen XZ
World J Gastroenterol; 2012 Jul; 18(27):3617-22. PubMed ID: 22826629
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.
Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R
BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
